UPDATE: Canaccord Genuity Starts The Beauty Health Company (SKIN) at Buy

June 15, 2021 6:34 AM EDT
Get Alerts SKIN Hot Sheet
Price: $18.34 +0.60%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 12 | New: 23
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Updated - June 15, 2021 7:10 AM EDT)

Canaccord Genuity analyst Kyle Rose initiates coverage on The Beauty Health Company (NASDAQ: SKIN) with a Buy rating and a price target of $21.00.

The analyst commented, "We view The Beauty Health Co. as a terrific example of a "category creator" within MedTech that is leveraging its existing technology platform, brand, and market insight to address an overlooked market segment. In this case, that means delivering innovative, non-invasive solutions that straddle multiple previously fragmented market
segments, including aesthetics, skincare/wellness, and experiential beauty."

For an analyst ratings summary and ratings history on The Beauty Health Company click here. For more ratings news on The Beauty Health Company click here.

Shares of The Beauty Health Company closed at $17.79 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

Canaccord Genuity